Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00328705 · ClinicalTrials.gov registry record · NA
D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management
A NA study of Heart Diseases, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 5
- Study locations
NCT00328705 is a NA study of Heart Diseases that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 65 participants, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 3 states.
The verdict
NCT00328705, a NA study of Heart Diseases, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.
Conditions Studied
Interventions
- DEVICE Implantable Cardioverter Defibrillator
Study Locations (5)
Minnesota
- - Coon Rapids
- - Rochester
- - Saint Paul
Florida
- - Tampa
North Carolina
- - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00328705
The ClinicalTrials.gov registry entry for NCT00328705 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Implantable Cardioverter Defibrillator is the first listed.
NCT00328705 reports 5 study locations spanning 3 distinct geographic areas - top geographies include Minnesota, Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00328705 about?
NCT00328705 is a clinical study titled "D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management". This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.
What is the current status of trial NCT00328705?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2006-05. Estimated completion is 2007-01.
What conditions does trial NCT00328705 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT00328705?
The interventions under investigation include: Implantable Cardioverter Defibrillator (DEVICE).
Who is sponsoring clinical trial NCT00328705?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00328705 being conducted?
This trial has 5 study locations across Florida, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
RECRUITING · NA
-
Use of Bedside Imaging and Community Health Workers for Early Screening and Referral of Pre-symptomatic Stage B Heart Failure in the Emergency Department
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.